Limnopharma
PrivateLast Round
Convertible Debt
Oct 5, 2022
Total Funding Raised
$320,000
Company Overview
Limnopharma operates in Healthcare & Life Sciences and is based in Granada. Its latest recorded funding round was a Convertible Debt round in October 2022.
Limnopharma is a pharmaceutical company that develops new therapies for retinal diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Limnopharma Comparables
Compare Limnopharma with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Miramón Pharma S.L. | 81% | |
| Nacuity Pharmaceuticals, Inc. | 80% | |
| Belite Bio, Inc | 77% |
For institutional investors. Book with your work email.
Limnopharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Convertible Debt | Oct 5, 2022 | ||||
| Accelerator | Dec 23, 2021 | ||||
| Grant | Dec 20, 2020 | ||||
| Seed | Mar 1, 2019 |
For institutional investors. Book with your work email.
Limnopharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| GENESIS Ventures | Series A, Seed |
| Center for Technological Development and Innovation | Grant |
| AcexHealth | Accelerator |
| Medex Partners | Series A |
| La Fondation de l'Avenir | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 5, 2022
Raised funding from Covirán S.C.A.
- Dec 23, 2021
$10K round led by AcexHealth
For institutional investors. Book with your work email.
Limnopharma Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Limnopharma's valuation, stock price, and market status.
Is Limnopharma a public or private company?
Limnopharma is a private company.
What is the current stock price of Limnopharma?
Limnopharma is a private company, so its shares have no public market price. Caplight tracks Limnopharma's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Limnopharma worth (valuation)?
Valuation information for Limnopharma is not publicly available.
Can I buy Limnopharma stock?
Limnopharma shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Limnopharma's last funding round?
Limnopharma's most recent funding round was Convertible Debt on October 5, 2022.
Who are the main investors in Limnopharma?
Key investors in Limnopharma include GENESIS Ventures.
Will Limnopharma IPO soon?
No public IPO plans have been announced for Limnopharma.
How can I track Limnopharma secondary market activity?
Caplight tracks bids, offers, and trades in Limnopharma's shares on secondary markets.